Advanced search
Publication Cover
Current Medical Research and Opinion Volume 30, 2014 - Issue 3
Submit an article Journal homepage
462
Views
6
CrossRef citations to date
0
Altmetric
Review

Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature

Angeliki ZarkaliAlfa Institute of Biomedical Sciences (AIBS) Marousi, AthensGreece
,
Drosos E. KarageorgopoulosAlfa Institute of Biomedical Sciences (AIBS), Marousi, Athens, Greece, Department of Medicine, Hygeia Hospital, Marousi, Athens, Greece, and Hellenic Center of Disease Control and Prevention Marousi, AthensGreece
,
Petros I. RafailidisAlfa Institute of Biomedical Sciences (AIBS), Marousi, Athens, Greece, and Department of Medicine, Henry Dunant Hospital AthensGreece
&
Matthew E. FalagasAlfa Institute of Biomedical Sciences (AIBS), Marousi, Athens, Greece, Department of Medicine, Henry Dunant Hospital, Athens, Greece, and Department of Medicine, Tufts University School of Medicine Boston, MAUSACorrespondence[email protected]
Pages 471-480 | Accepted 27 Sep 2013, Published online: 12 Nov 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Matthew E. Falagas, Andreas D. Mavroudis & Konstantinos Z. Vardakas. (2016) The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?. Expert Review of Anti-infective Therapy 14:8, pages 747-763.
Read now

Articles from other publishers (5)

Katrina Howe, Siobhan Bourke & Lloyd Sansom. (2021) The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: A scoping review. PLOS ONE 16:12, pages e0261022.
Crossref
Anabel Torrente-López, Jesús Hermosilla, Natalia Navas, Luis Cuadros-Rodríguez, José Cabeza & Antonio Salmerón-García. (2021) The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines 9:6, pages 557.
Crossref
María Antonia Meroño Saura, María Dolores Nájera Pérez, Francisco Ayala de la Peña, Taida María Rodríguez Martínez, Celia Fernández Zamora & Josefa León Villar. (2020) Análisis del uso de fármacos fuera de indicación autorizada en hematología y oncología. Revista Colombiana de Cancerología 24:1, pages 3-10.
Crossref
László Gulácsi, Valentin Brodszky, Petra Baji, Fanni Rencz & Márta Péntek. (2017) The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries. Advances in Therapy 34:5, pages 1128-1144.
Crossref
D Salat, R Llop, C Aguilera, I Danés, M Bosch, C Asensio, F Castañeda, E Esterlich & A Vallano. (2016) Therapeutic enquiries about biological agents as a tool to identify safety aspects and patterns of use. European Journal of Hospital Pharmacy 23:3, pages 161-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.